Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Tack

Showing results (531-540 of 727) with videos related to

Pageof 73
Sort By:
Neurogastroenterology and Motility|May 22, 2016
The effect of arabinoxylooligosaccharides on gastric sensory-motor function and nutrient tolerance in manE Scarpellini, E Deloose, R Vos, et al.
The Journal of Clinical Endocrinology and Metabolism|May 6, 2004
Plasma metanephrine levels are decreased in type 1 diabetic patients with a severely impaired epinephrine response to hypoglycemia, indicating reduced adrenomedullary stores of epinephrineBastiaan E De Galan, Cees J Tack, Jacques J Willemsen, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|February 7, 2014
Dietary lipids do not contribute to the higher hepatic triglyceride levels of fructose- compared to glucose-fed micePatricia M Nunes, Alan J Wright, Andor Veltien, et al.
Clinical Pharmacology and Therapeutics|November 4, 2011
Differences in pharmacological activities of the antioxidant flavonoid monoHER in humans and mice are caused by variations in its metabolic profileH Jacobs, G H Koek, R Peters, et al.
Neurogastroenterology and Motility|April 23, 2014
A pilot study of the effects of the somatostatin analog pasireotide in postoperative dumping syndromeE Deloose, R Bisschops, L Holvoet, et al.
Diabetes, Obesity & Metabolism|July 22, 2014
The interleukin-1 receptor antagonist anakinra improves first-phase insulin secretion and insulinogenic index in subjects with impaired glucose toleranceP C M van Poppel, E J P van Asseldonk, J J Holst, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|June 16, 2010
Prevalence of comorbid depression is high in out-patients with Type 1 or Type 2 diabetes mellitus. Results from three out-patient clinics in the NetherlandsF Pouwer, P H L M Geelhoed-Duijvestijn, C J Tack, et al.
Pharmacogenetics and Genomics|March 13, 2008
The Arg16Gly variant of the beta2-adrenergic receptor predisposes to hypoglycemia unawareness in type 1 diabetes mellitusBas J Schouwenberg, Bart A Veldman, Wilko Spiering, et al.
Expert Review of Proteomics|November 24, 2018
The future of protein biomarker research in type 2 diabetes mellitusRoel Tans, Lars Verschuren, Hans J C T Wessels, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 6, 2005
Energy homeostasis and gastric emptying in ghrelin knockout miceB De Smet, I Depoortere, D Moechars, et al.
Pageof 73

Showing results (531-540 of 727) with videos related to

Sort By:
Pageof 73
Neurogastroenterology and Motility|May 22, 2016
The effect of arabinoxylooligosaccharides on gastric sensory-motor function and nutrient tolerance in manE Scarpellini, E Deloose, R Vos, et al.
The Journal of Clinical Endocrinology and Metabolism|May 6, 2004
Plasma metanephrine levels are decreased in type 1 diabetic patients with a severely impaired epinephrine response to hypoglycemia, indicating reduced adrenomedullary stores of epinephrineBastiaan E De Galan, Cees J Tack, Jacques J Willemsen, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|February 7, 2014
Dietary lipids do not contribute to the higher hepatic triglyceride levels of fructose- compared to glucose-fed micePatricia M Nunes, Alan J Wright, Andor Veltien, et al.
Clinical Pharmacology and Therapeutics|November 4, 2011
Differences in pharmacological activities of the antioxidant flavonoid monoHER in humans and mice are caused by variations in its metabolic profileH Jacobs, G H Koek, R Peters, et al.
Neurogastroenterology and Motility|April 23, 2014
A pilot study of the effects of the somatostatin analog pasireotide in postoperative dumping syndromeE Deloose, R Bisschops, L Holvoet, et al.
Diabetes, Obesity & Metabolism|July 22, 2014
The interleukin-1 receptor antagonist anakinra improves first-phase insulin secretion and insulinogenic index in subjects with impaired glucose toleranceP C M van Poppel, E J P van Asseldonk, J J Holst, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|June 16, 2010
Prevalence of comorbid depression is high in out-patients with Type 1 or Type 2 diabetes mellitus. Results from three out-patient clinics in the NetherlandsF Pouwer, P H L M Geelhoed-Duijvestijn, C J Tack, et al.
Pharmacogenetics and Genomics|March 13, 2008
The Arg16Gly variant of the beta2-adrenergic receptor predisposes to hypoglycemia unawareness in type 1 diabetes mellitusBas J Schouwenberg, Bart A Veldman, Wilko Spiering, et al.
Expert Review of Proteomics|November 24, 2018
The future of protein biomarker research in type 2 diabetes mellitusRoel Tans, Lars Verschuren, Hans J C T Wessels, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 6, 2005
Energy homeostasis and gastric emptying in ghrelin knockout miceB De Smet, I Depoortere, D Moechars, et al.
Pageof 73